Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Molecules ; 20(3): 5038-49, 2015 Mar 19.
Artigo em Inglês | MEDLINE | ID: mdl-25808148

RESUMO

A number of studies have proposed an anti-diabetic effect for tarchonanthuslactone based on its structural similarity with caffeic acid, a compound known for its blood glucose-reducing properties. However, the actual effect of tarchonanthuslactone on blood glucose level has never been tested. Here, we report that, in opposition to the common sense, tarchonanthuslactone has a glucose-increasing effect in a mouse model of obesity and type 2 diabetes mellitus. The effect is acute and non-cumulative and is present only in diabetic mice. In lean, glucose-tolerant mice, despite a slight increase in blood glucose levels, the effect was not significant.


Assuntos
Glicemia/efeitos dos fármacos , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Obesidade/metabolismo , Pironas/administração & dosagem , Animais , Modelos Animais de Doenças , Injeções Intraperitoneais , Masculino , Camundongos , Pironas/química , Pironas/farmacologia
2.
J Org Chem ; 79(2): 630-42, 2014 Jan 17.
Artigo em Inglês | MEDLINE | ID: mdl-24359482

RESUMO

The interface between synthetic organic chemistry and natural products was explored in order to unravel the structure of coibacin A, a metabolite isolated from the marine cyanobacterium cf. Oscillatoria sp. that exhibits selective antileishmanial activity and potent anti-inflammatory properties. Our synthetic plan focused on a convergent strategy that allows rapid access to the desired target by coupling of three key fragments involving E-selective Wittig and modified Julia olefinations. CD measurements and comparative HPLC analyses of the natural product and four synthetic stereoisomers led to determination of its absolute configuration, thus correcting the original assignment at C-5 and unambiguously establishing those at C-16 and C-18. Additionally, we synthesized coibacin B on the basis of the assignment of configuration for coibacin A.


Assuntos
Cetonas/química , Cetonas/síntese química , Lactonas/química , Lactonas/síntese química , Oscillatoria/química , Cetonas/isolamento & purificação , Lactonas/isolamento & purificação , Conformação Molecular , Estereoisomerismo
3.
Eur J Med Chem ; 46(4): 1245-53, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21334796

RESUMO

In this study, we describe the rational design, molecular modeling and pharmacological profile of a novel IKK-ß inhibitor (E)-N-(4-nitrobenzylidene)-2-naphthohydrazide (LASSBio-1524). The design based on the IKK-ß active site, and a privileged structure template yielded a novel IKK-ß inhibitor scaffold with significant selectivity over IKK-α and CHK2, as assessed by an in vitro kinase assay. For a better understanding of the structural requirements of IKK-ß inhibition, molecular dynamics simulations of LASSBio-1524 (3) were performed. The NAH derivative LASSBio-1524 (3), was able to suppress arachidonic acid-induced edema formation in a dose-dependent manner, demonstrating an in vivo anti-inflammatory effect. The molecular architecture of this novel, low-molecular weight IKK-ß inhibitor is encouraging for further lead optimization toward the development of innovative anti-inflammatory drug candidates.


Assuntos
Compostos de Benzilideno/química , Compostos de Benzilideno/farmacologia , Desenho de Fármacos , Hidrazonas/química , Hidrazonas/farmacologia , Quinase I-kappa B/antagonistas & inibidores , Inibidores de Proteínas Quinases/química , Inibidores de Proteínas Quinases/farmacologia , Sequência de Aminoácidos , Animais , Anti-Inflamatórios/síntese química , Anti-Inflamatórios/química , Anti-Inflamatórios/farmacologia , Anti-Inflamatórios/uso terapêutico , Compostos de Benzilideno/síntese química , Compostos de Benzilideno/uso terapêutico , Domínio Catalítico , Linhagem Celular , Edema/induzido quimicamente , Edema/tratamento farmacológico , Feminino , Humanos , Hidrazonas/síntese química , Hidrazonas/uso terapêutico , Quinase I-kappa B/química , Ligantes , Masculino , Camundongos , Simulação de Dinâmica Molecular , Dados de Sequência Molecular , Peso Molecular , Inibidores de Proteínas Quinases/síntese química , Inibidores de Proteínas Quinases/uso terapêutico
4.
Bioorg Med Chem Lett ; 19(24): 6907-10, 2009 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-19896375

RESUMO

This Letter describes the results of two combined approaches: homology modeling and molecular docking studies, in order to propose the molecular basis of IKKbeta inhibition by staurosporine and quercetin as ATP-competitive inhibitors. The results provides a rationale and structural frameworks for designing potent ATP binding-site inhibitors of IKKbeta, which is an attractive drug target for inflammatory diseases and has been found to be responsible for some of the already observed pharmacological effects for marketed drugs.


Assuntos
Produtos Biológicos/química , Quinase I-kappa B/antagonistas & inibidores , Quercetina/química , Estaurosporina/química , Produtos Biológicos/farmacologia , Desenho de Fármacos , Quercetina/farmacologia , Estaurosporina/farmacologia , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA